MX2022016267A - Lubricantes personales que comprenden lambda-carragenina. - Google Patents

Lubricantes personales que comprenden lambda-carragenina.

Info

Publication number
MX2022016267A
MX2022016267A MX2022016267A MX2022016267A MX2022016267A MX 2022016267 A MX2022016267 A MX 2022016267A MX 2022016267 A MX2022016267 A MX 2022016267A MX 2022016267 A MX2022016267 A MX 2022016267A MX 2022016267 A MX2022016267 A MX 2022016267A
Authority
MX
Mexico
Prior art keywords
viruses
carragenine
lambda
sexually
personal lubricants
Prior art date
Application number
MX2022016267A
Other languages
English (en)
Spanish (es)
Inventor
Mario Elmen Tremblay
Original Assignee
Mario Elmen Tremblay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mario Elmen Tremblay filed Critical Mario Elmen Tremblay
Publication of MX2022016267A publication Critical patent/MX2022016267A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2022016267A 2020-06-22 2020-06-22 Lubricantes personales que comprenden lambda-carragenina. MX2022016267A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2020/038991 WO2021262141A1 (en) 2020-06-22 2020-06-22 Personal lubricants comprising lambda-carrageenan

Publications (1)

Publication Number Publication Date
MX2022016267A true MX2022016267A (es) 2023-03-31

Family

ID=79281651

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022016267A MX2022016267A (es) 2020-06-22 2020-06-22 Lubricantes personales que comprenden lambda-carragenina.

Country Status (9)

Country Link
EP (1) EP4167956A4 (de)
JP (1) JP7635277B2 (de)
KR (1) KR20230042020A (de)
CN (1) CN115942941A (de)
AU (1) AU2020454698A1 (de)
BR (1) BR112022026026A2 (de)
CA (1) CA3183518A1 (de)
MX (1) MX2022016267A (de)
WO (1) WO2021262141A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230285284A1 (en) * 2022-03-10 2023-09-14 Elizabeth McQuaid Lubricant pods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1471914A (zh) * 2003-04-29 2004-02-04 胡世玺 防治由sars病毒引起的非典型肺炎的药物和应用及其制备方法
US20050239742A1 (en) * 2004-04-08 2005-10-27 Vivus, Inc. Carrageenan-based formulations and associated methods of use
KR20080070482A (ko) * 2007-05-31 2008-07-30 (주)디딤바이오텍 점막면역 유도능이 있는 면역증강제를 포함하는 윤활제조성물 및 이의 제조방법
US20110229446A1 (en) * 2010-03-02 2011-09-22 Roman Stephen B Method and composition to relieve sexual discomfort and improve vaginal health
JP6170044B2 (ja) * 2011-07-20 2017-07-26 エフ． カイザー，パトリック 薬物送達のための膣内デバイス
CN107847430B (zh) * 2015-07-14 2021-02-02 玛丽诺姆德生物技术股份公司 一种具有抗病毒活性的鼻塞疏通组合物
US20180369137A1 (en) * 2017-06-27 2018-12-27 Lifestyles Healthcare Pte. Ltd. Natural Lubricant
ES3037144T3 (en) * 2018-05-10 2025-09-29 Lanvira Llc Lubricated substrates comprising lambda-carrageenan

Also Published As

Publication number Publication date
EP4167956A1 (de) 2023-04-26
WO2021262141A1 (en) 2021-12-30
AU2020454698A1 (en) 2023-02-23
CA3183518A1 (en) 2021-12-30
KR20230042020A (ko) 2023-03-27
BR112022026026A2 (pt) 2023-03-07
JP7635277B2 (ja) 2025-02-25
JP2023538798A (ja) 2023-09-12
CN115942941A (zh) 2023-04-07
EP4167956A4 (de) 2024-02-21

Similar Documents

Publication Publication Date Title
CU20190045A7 (es) Compuestos derivados de 1,2,4-triazolonas 2,4,5-trisustituidas que son inhibidores de la dihidroorotato deshidrogenasa (dhodh) útiles para el tratamiento o prevención de trastornos hiperproliferativos e inflamatorios
MX372625B (es) Composicion para desobstruir la nariz congestionada que tiene actividad antiviral
MY175587A (en) Fire extinguishing composition containing saccharide and saccharide derivative
CR11723A (es) Agente para tratar enfermedad
EA201270749A1 (ru) Композиции с вирусным ингибитором для терапевтического применения in vivo, включающие сочетание (-)-карвона, (+) карвона, гераниола и дополнительного эфиромасличного компонента
EP4342539A3 (de) Geschmierte substrate mit lambda-carrageenan
MX2022016267A (es) Lubricantes personales que comprenden lambda-carragenina.
BR112014012463A2 (pt) agente protetor para ceratoconjuntiva ou agente supressor para distúrbio ceratoconjuntival
BR112021018924A2 (pt) Derivado de heterocíclico pirrol, método de preparação do mesmo e aplicação do mesmo em medicamento
BR112022016131A2 (pt) Compostos para tratamento de infecção por coronavírus
PE20211113A1 (es) Agentes de liberacion de gas antimicrobianos y sistemas y metodos para utilizarlos
WO2021046315A3 (en) Inhibitors of encephalitic alphaviruses
AU2020235128A8 (en) Transparent or semitransparent inverse microlatices of polyacrylamide as oil emulsion drift reducing agent
MX2013002649A (es) Agente terapeutico contra el dolor.
WO2022106460A3 (en) Steroid sparing
BR112018013907A2 (pt) composições de agente de expulsão para espécies de enxofre
MX2021005530A (es) Composición defensiva de fluido no letal y sistema de suministro presurizado.
ZA202211253B (en) Compositions comprising 15-hepe for treating or preventing hematologic disorders, and/or related diseases
MX2016009475A (es) Composiciones efectivas contra la conjuntivitis viral.
MX2016008546A (es) Reduccion de queloides utilizando alantoina topica.
BR0315016A (pt) Composição fumìgena
GEP20247629B (en) Alcohol derivatives as kv7 potassium channel openers
MX2021010018A (es) Anticonceptivos unisex no hormonales.
EA201491167A1 (ru) Вагинальное кольцо, содержащее мелоксикам и агент для модулирования высвобождения активного ингредиента, для применения у женщин в качестве контрацептива для постоянного использования
MX362592B (es) Supresion de olor de los compuestos analgesicos organicos volatiles y metodo de uso.